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Abstract
Background: Growth factor receptor bound (Grb) proteins 7, 10 and 14 are a family of structurally related multi-
domain adaptor proteins involved in a variety of biological processes. Grb7, 10 and 14 are known to become
serine and/or threonine phosphorylated in response to growth factor (GF) stimulation. Grb7 and 10 have also been
shown to become tyrosine phosphorylated under certain conditions. Under experimental conditions Grb7 is
tyrosine phosphorylated by the Tie2/Tie-2/Tek angiogenic receptor tyrosine kinase (RTK). Furthermore, Grb14 has
also been shown to interact with Tie2, however tyrosine phosphorylation of this Grb family member has yet to be
reported.
Results: Here we report for the first time tyrosine phosphorylation of Grb14. This phosphorylation requires a kinase
competent Tie2 as well as intact tyrosines 1100 and 1106 (Y1100 and Y1106) on the receptor. Furthermore, a
complete SH2 domain on Grb14 is required for Grb14 tyrosine phosphorylation by Tie2. Grb14 was also able to
become tyrosine phosphorylated in primary endothelial cells when treated with a soluble and potent variant of the
Tie2 ligand, cartilage oligomeric matrix protein (COMP) Ang1.
Conclusion: Our results show that Grb14, like its family members Grb7 and Grb10, is able to be tyrosine
phosphorylated. Furthermore, our data indicate a role for Grb14 in endothelial signaling downstream of the Tie2
receptor.
Background
Signal transduction pathways encompass a series of
highly coordinated events involving numerous proteins,
varying in both structure and function. Adaptor proteins
play a pivotal role in such molecular networks by allow-
ing formation of protein complexes via interactions
involving their non-catalytic binding domains. The
Growth factor Receptor Bound (Grb) adaptor proteins
are a group of structurally similar proteins beginning to
emerge as key players in a number of cellular functions
including cell metabolism, cell survival and cell
migration.
The Grb family is made up of three members, Grb7,10
and 14. All family members harbor an amino-terminal
proline rich region (PRR), a putative Ras associating
(RA) domain, a pleckstrin homology (PH) domain and a
carboxyl-terminal SH2 domain. Furthermore, unique to
this family of proteins is a novel interaction region, the
BPS (for Between PH and SH2) domain. To date the
BPS domain has been shown to play a role in certain
Grb/receptor interactions including those involving the
activated Insulin receptor (IR) and Insulin-like Growth
Factor Receptor [1].
While all three family members were originally cloned
in screens using the EGFR as bait, as with most other
SH2 containing proteins it was quickly discovered that
this family of adaptors binds a number of other receptor
and non-receptor proteins. Included in these is the
angiogenic Tie2/Tie-2/Tek receptor tyrosine kinase
(RTK). Tie2 is a RTK found primarily on the surface of
endothelial cells. Mouse molecular models have shown
an essential role for this receptor in aspects of angiogen-
esis. Tie2 deficient mice present with a plethora of vas-
cular abnormalities including a lack of proper sprouting
and remodeling of the primitive vessel network [2,3]. In
the adult, Tie2 has been implicated in both normal and
pathological states including wound healing, follicular
development, diabetic retinopathy and tumorigenesis.
Tie2 belongs to the Tie family of proteins. While the
only other family member, Tie/Tie-1, remains an orphan
receptor, a family of ligands known as the angiopoietins
(Angs) have been shown to play a role in Tie2 biology.
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Currently, Ang1 remains the best characterized of the
angiopoietins and is believed to be the main activating
ligand for Tie2. It has been shown to activate the Tie2
receptor and contribute to such functions as endothelial
cell survival and migration [4].
Jones et al. initially demonstrated Grb7 and Grb14
interactions with Tie2 in a yeast two-hybrid screen
using cDNAs derived from embryonic mouse heart and
lung tissue [5]. Overexpression studies further demon-
strated that the Grb7/Tie2 interaction was mediated by
a multidocking site, tyrosine 1100, on Tie2. Further-
more, Grb7 becomes tyrosine phosphorylated in the
presence of a kinase competent Tie2 receptor.
The Grb family of proteins are known to be phos-
phorylated on serine, threonine and tyrosine residues,
although the functional significance of these phosphory-
lations are still unclear in most cases. Grb7 is phop-
shorylated on serine and threonine residues in both
quiescent and growth factor (GF) stimulated cells,
although GF stimulation does not appear to alter Grb7
phosphorylation state [6,7]. Grb7 has also been shown
to be tyrosine phosphorylated by a number of different
kinases, including FAK at sites of focal adhesion and,in
the presence of certain GFs such as EGF, and ephrinB1
and in the presence of receptors such as Tie2, Ret and
HER2/erbB-2 [5,6].
In contrast to Grb7, both Grb10 and Grb14 possess
basal serine phosphorylation which can be further
induced by GF stimulation [8-11]. Grb10 has also been
shown to be tyrosine phosphorylated in insulin signaling
and in the presence of active Tec [12-14]. To date, there
are no previous reports of Grb14 tyrosine phosphoryla-
tion, although it has been predicted to occur under cer-
tain conditions given its interaction with numerous
RTKs and its similar structure to Grb7 and 10.
Here we report for the first time Grb14 tyrosine phos-
phorylation. This phosphorylation appears to be depen-
dent on the presence of Tie2 kinase activity and appears
to involve tyrosine residues 1100 and 1106 of the Tie2
RTK as well as an intact SH2 domain on Grb14.
Results
Grb14 becomes tyrosine phosphorylated in the presence
of Tie2
While both Grb7 and Grb10 have been reported to be
tyrosine phosphorylated [5,6,12-14], Grb14 has only
been found to become phosphorylated on serine and
threonine residues [9,10]. Because Tie2 is a known tyro-
sine kinase, we set out to determine whether or not
Grb14 could become tyrosine phosphorylated in the
presence of this receptor. 293T kidney epithelial cells
were transfected with Grb14 either alone or with the
wild type receptor (WT) or a kinase inactive mutant of
Tie2, K853A. Cell lysates from these transfections were
then subjected to immunoprecipitation using an anti-
Grb14 antibody and blotted for phospho-tyrosine (Fig-
ure 1). Grb14 becomes tyrosine phosphorylated in the
presence of the wild type receptor (WT) but not vector
or K853A. This shows for the first time that Grb14 can
be tyrosine phosphorylated and in this case, phosphory-
lation is dependent on the presence of the Tie2 kinase.
Y1100 and Y1106 on Tie2 are important for Grb14
tyrosine phosphorylation
RTKs function by autophosphorylating on tyrosine resi-
dues in their intracellular domain upon activation, often
providing binding sites to various proteins containing
phospho-tyrosine binding domains. Grb14 contains a C-
terminal SH2 domain and is believed to bind to Tie2 via
one of the receptor’s phospho-tyrosine residues. We used
a number of Tie2 tyrosine to phenylalanine point mutants
in order to determine whether or not mutation of any of
these tyrosine residues on Tie2 altered Grb14 phosphory-
lation. 293T cells were transfected with Grb14 alone or in
combination with wild type Tie2, the kinase deficient Tie2
(K853A) or one of the Tie2 tyrosine mutants (Y1100F,
Y1106F, Y1111F, Y1100/1106F). While mutation of any
one of the Tie2 tyrosine residues did not appear to alter
Grb14 phosphorylation significantly, when both Y1100
and Y1106 were mutated on the same receptor (Y1100/
1106) there was a marked decrease in Grb14 tyrosine
phosphorylation (Figure 2A). This suggests that Y1100
and Y1106 on Tie2 play a role in Grb14 mediated signal
transduction downstream of this receptor.
Previous studies have shown that mutation of receptor
tyrosine residues to phenylalanine (such as in our Tie2
Figure 1 Grb14 is tyrosine phosphorylated in the presence of
Tie2. 293T kidney epithelial cells were transfected with Grb14 either
alone or with the wild type receptor (Tie2) or a kinase inactive
mutant of Tie2 (K853A). Cell lysates from these transfections were
then subjected to immunoprecipitation using an anti-Grb14
antibody and blotted for phospho-tyrosine (4G10) or anti-FLAG to
check for Grb14 amount precipitated.
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mutants) can affect kinase activity of the receptor. In
order to determine if the substitution of Y1100 or 1106
results in a decreased in kinase activity, we carried out a
kinase assay to compare the kinase activity of the
Y1100F, Y1106F and Y1100/1106F mutants to that of
the wild type receptor using a GST Dok-R fusion pro-
tein as substrate. Dok-R is a docking protein that
becomes tyrosine phosphorylated downstream of Tie2
in vivo making it a biologically relevant choice for a sub-
strate. The Dok-R construct used herein lacks the inso-
luble PH domain to facilitate purification and will be
subsequently referred to as C (described previously in
[15]. An equal amount of receptor was immunoprecipi-
tated from 293T cells expressing Tie2WT, K853A or
one of the Tie2 mutants (Y1100F, Y1106F or Y1100/
1106F) and incubated in a kinase reaction with set
amounts of glutothione-Sepharose purified GST-Dok-
PΔPH and 32P labeled ATP. Figure 2B is a representative
blot of two separate experiments demonstrating ability
of Y1100/1106F to phosphorylate GST-Dok-PΔPH. These
data show that while there appears to be a slight
decrease in Y1100/1106F kinase activity when compared
to Tie2WT, Y1100/1106F activity is comparable to that
of the Y1106F mutant. Recall from Figure 2A that
Grb14 was phosphorylated in the presence of Y1106F
mutant to similar levels as when in the presence of the
wild type receptor indicating that the level of kinase
activity of the Y1106 mutant is adequate for phosphory-
lation of Grb14. By inference, therefore, we believe it is
unlikely that the decrease in kinase activity seen here
for Y1100/1106F is the cause of the dramatic decrease
in Grb14 tyrosine phosphorylation observed in our over-
expression studies.
Grb14 SH2 domain is important for Grb14 tyrosine
phosphorylation
Both SH2 and BPS domains of the Grb family members
have been shown to mediate interactions with various
receptor and non-receptor proteins. In order to investi-
gate whether or not the SH2 domain of Grb14 is able to
bind Tie2 we performed an in vitro pull down assay
using the full length Tie2 receptor and the SH2 domain
of Grb14. Grb14 and Grb2 (as a positive control) SH2
domains were purified from E. coli and immobilized on
glutathione-Sepharose beads. GST-SH2 domains were
then incubated with lysates from HEK293T cells transi-
ently expressing either WT Tie2 or the kinase inactive
K853A mutant. The SH2 domains of both Grb2 and
Grb14 were both able to pull down WT Tie2, but not
K853A (Figure 3A) indicating the ability of the Grb14
SH2 domain to interact with Tie2. The increased ability
of Grb14 to pull-down Tie2 as compared to Grb2 may
reflect a greater interaction with Tie2. Cell lysate from
transfected cells was analyzed to confirm transfection
and protein expression in 293T cells.
Mutation of the SH2 domain FLVRS motif has been
shown to disrupt SH2 domain function. We generated
an Arg to Lys (R646K) mutation in the Grb14 SH2
domain within this conserved FLVRS motif in order to
determine the effect of disrupting Grb14 SH2 function
on Grb14 tyrosine phosphorylation. HEK293T cells were
transfected with WT Tie2 or the K853A mutant along
with either WT Grb14 or our Grb14FLVRS mutant.
Lysates from these cells were immunoprecipitated with
anti-FLAG antibody and subjected to Western blot
using a phospho-tyrosine specific antibody (Figure 3B).
Figure 3B shows that mutation of the Grb14 FLVRS
motif abolishes tyrosine phosphorylation of Grb14 sug-
gesting the functionality of this domain must be intact
for Tie2 mediated Grb14 tyrosine phosphorylation. Blots
were stripped and reprobed using anti-Tie2 and anti-
FLAG antibodies as controls. Together these results
Figure 2 Y1100 and Y1106 on Tie2 are important for Grb14
tyrosine phosphorylation. HEK293T cells were transfected with
Grb14 alone or in combination with wild type Tie2, the kinase
deficient Tie2 (K853A) or one of the Tie2 tyrosine mutants (Y1100F,
Y1106F, Y1111F, Y1100/1106F). A) Lysates (100 μg) from these cells
were immunoprecipitated using an antibody specific for Grb14, run
out on an SDS PAGE gel and blotted for phosphotyrosine (top
panel). Cell lysates (20 μg) were also run out on an SDS PAGE gel
and subjected to Western blotting using an anti-Grb14 antibody as
a control (bottom panel). B) Lysates were immunoprecipitated with
an anti-Tie2 antibody and then either subjected to Western Blot
using anti-Tie2 antibodies (top panel) or incubated in a kinase
reaction with set amounts of glutathione-Sepharose purified GST-
Dok-PΔPH and 32P-labeled ATP (bottom panel).
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suggest a role for the Grb14 SH2 domain in Tie2
mediated Grb14 signaling.
Grb14 phosphorylation in endothelial cells
A yeast-two hybrid screen using cDNA derived from
murine embryonic heart and lung tissue and the intra-
cellular portion of the Tie2 receptor initially identified
Grb14 as a binding partner of Tie2 [5]. To date, Tie2
has been shown to be found predominantly in endothe-
lial cells. In order to verify that Grb14 is a potentially
biologically relevant player in the Tie2 signaling path-
way, we examined for the presence of Grb14 in a num-
ber of endothelial cell lines. Four murine (C166, EOMA,
SVR and SVEC) and one human (EAhy92.6) endothelial
cell lines as well as an HEK293 cell line that stably
expresses the full-length Tie2 receptor (HEK293Tie2)
were immunoprecipitated and then subjected to
Western Blotting using an antibody specific for Grb14
(Figure 4A). Cell lysate from 293T cells overexpressing
Grb14 was also run as a positive control for Grb14. The
results show that Grb14 is present in three of the five
endothelial cell lines examined (EOMA, SVEC and
EAhy92.6). These results were confirmed by RT-PCR
(data not shown). This data demonstrates that Grb14 is
in fact present in endothelial cells and therefore is a rea-
sonable candidate for a player in the Tie2 signaling
pathway.
Angiopoietin-1 (Ang1) is a known ligand of Tie2 in
endothelial cells inducing the Tie2 signalling pathway.
In order to verify whether or not endogenous Grb14 is
able to be tyrosine phosphorylated in endothelial cells,
we stimulated HUVEC cells with a soluble and potent
variant of the Tie2 ligand, cartilage oligomeric matrix
protein (COMP)-Ang1 [16]. Cell lysate from either
unstimulated cells or cells treated with COMP-Ang1
was run on a gel and probed for phosphotyrosine.
Figure 3 The SH2 domain is important for Grb14 tyrosine
phosphorylation. A) HEK 293T cells were transfected with Tie2,
either WT or the kinase inactive K853A mutant. Lysates were
incubated with immobilized GST alone, GST-SH2 domains from Grb2
(control) or Grb14 (as indicated). Resulting complexes were resolved
by SDS-PAGE and immunoblotted with anti-Tie2 antibodies. B) HEK
293T cells were co-transfected with Tie2 (WT or kinase inactive) and
FLAG tagged Grb14 (WT or the FLVRS mutant). Lysates subjected to
immunoprecipitation by either Tie2 or FLAG antibodies and
resolved by SDS-PAGE. Western blotting with indicated antibodies
was then carried out.
Figure 4 Tyrosine phosphorylation of Grb14 in endothelial
cells. A) Lysates from C166, EOMA, SVR, SVEC and EAhy92.6
endothelial cell lines as well as an HEK293 cell line that stably
expresses the full-length Tie2 receptor (HEK293Tie2) were
immunoprecipitated and then subjected to Western Blotting using
an antibody specific for Grb14. Cell lysate from 293T cells
overexpressing Grb14 was also run as a positive control. B) Human
umbilical endothelial cells (HUVEC) were either left untreated or
stimulated with the soluble and potent variant of the Tie2 ligand,
cartilage oligomeric matrix protein (COMP) Ang1. Cell lysates were
immunoprecipitated with anti-Grb14 and subjected to SDS PAGE
and Western blotted for phosphotyrosine with 4G10 antibody. The
positive control lane was protein sample derived from Grb14/
Tie2Y1111 transfected 293T cells
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Lysate from 293T cells transfected with Y1111F and
Grb14 was run as a positive control for Grb14 phos-
phorylation. Figure 4B shows a tyrosine phosphorylated
protein running at the same size as our positive control
in the COMP-Ang1 sitmulated lane, but to a much les-
ser extent in the unstimulated sample. This data sug-
gests that Grb14 is phosphorylated in endothelial cells
upon stimulation with the Ang1 variant, COMP-Ang1.
Discussion
Although the Grb family of proteins was described for
the first time over a decade ago, still much has to be
learned about the role of these adaptors in various sig-
naling pathways. Most of what we know about these
proteins has come from binding studies and elucidation
of the various domains involved in these interactions.
Grb7, 10 and 14 have been shown to bind a number of
receptors and intracellular proteins primarily via SH2
mediated interactions, although the importance of the
BPS domain is also becoming apparent.
Grb14 was previously identified in a yeast two-hybrid
screen as a binding partner for the endothelial receptor
Tie2 [5]. Tie2 is an angiogenic RTK involved in numerous
aspects of endothelial biology such as cell migration, cell
survival and tubule formation. We have now been able to
show that Grb14 is endogenous to endothelial cells further
supporting a role for Grb14 in endothelial cell signaling.
Furthermore, the results reported herein are the first to
describe tyrosine phosphorylation of Grb14. This phos-
phorylation appears to require a kinase competent Tie2
and tyrosines 1100 and 1106 on the receptor.
Phosphorylation is the most widespread post-transla-
tional protein modification in cell signaling [17]. Phos-
phorylation of a protein can modulate its behavior in a
multitude of ways including its function, localization,
half life and binding to other molecules [18]. In eukar-
yotes, phosphorylation is typically ‘carried out’ on serine,
threonine or tyrosine residues.
Since there discovery, Grb family members have been
shown become phosphorylated under a number of var-
ious conditions. The role of this phosphorylation, how-
ever, remains somewhat enigmatic. All family memebers
(Grb7, 10 and 14) have been shown to possess both
basal and growth factor induced serine phosphorylation
(reviewed in Holt, 2005 [19]). Grb10 and Grb7 have also
been shown to be tyrosine phosphorylated. More specifi-
cally, Grb10 and Grb7 tyrosine phosphorylation has
been previously implicated in signaling downstream of
endothelial receptors. Grb10 has been shown to be tyro-
sine phosphorylated in endothelial cells by VEGF [20].
Our lab has also previously shown that Grb7 becomes
tyrosine phosphorylated in the presence of the endothe-
lial receptor Tie2 [5]. Taken together, these data sup-
ports a role for Grb proteins in endothelial biology.
The current study suggests that Grb14 tyrosine phos-
phorylation requires a kinase competent Tie2 receptor.
In a separate experiment, Grb14 was not tyrosine phos-
phorylated in the presence of EGFR suggesting some spe-
cificity for the Tie2 kinase (data not shown). Whether or
not Grb14 is a direct substrate of the Tie2 kinase activity,
or rather is phosphorylated by an alternate kinase
recruited to this receptor, remains to be seen.
Grb proteins do not possess intrinsic kinase activity,
but have been shown to bind a number of receptor and
non-receptor kinases (reviewed in [7,19,21]. In insulin
signaling, Grb10 serine phosphorylation appears to
involve the Pi3K and MAPK signaling pathways, while
PKCζ seems to play a role in Grb14 phosphorylation
[11,22]. Grb proteins have been found to bind a number
of tyrosine kinases (reviewed in Holt and Siddle, 2005
[19]). Interestingly, in the case of insulin signaling,
although Grb10 and Grb14 bind the IR, they do not
appear to be direct substrates for the IR tyrosine kinase
activity [13,23]. Instead, at least with respect to Grb10,
Src/Fyn kinases were suggested to be responsible. In
general, how and why Grb proteins are phosphorylated
remains to be determined in most cases.
In our studies, Grb14 tyrosine phosphorylation was
abolished upon mutation of Y1100 and Y1106 to pheny-
lalanine in the receptor double mutant Tie21100/1106,
suggesting these two residues may play a role in Grb14
tyrosine phosphorylation downstream of Tie2. This
should perhaps not be surprising given that there is
emerging evidence that the Grb family members may
bind their target proteins via two separate regions, the
SH2 and BPS domains (Reviewed in Holt and Siddle,
2005 [19]).
This is particularly evident in the case of insulin sig-
naling where both SH2 and BPS domains of Grb 7, 10
and 14 have been shown to bind the IR [19]. Specifi-
cally, structural studies have shown that the Grb14 SH2
and BPS domains bind phosphorylated tyrosine residues
within the IR activation loop [24]. Whether tyrosines
1100 and 1106 bind Grb14 directly or play a more indir-
ect role in Grb14 tyrosine phosphorylation, however,
remains to be determined.
It is interesting to note that in comparison with the
other Grb family members, Grb14 has been shown to
interact with a relatively small number of receptors. In
accordance with this observation, we have found in vivo
binding studies of Grb14 and Tie2 have been particu-
larly challenging (data not shown). This may be
explained, at least in part, by structural studies which
have shown that Grb14 may have more difficulty bind-
ing to phosphotyrosine containing ligands due to the
presence of a non-glycyl residue at the end of the BC
loop and the lack of a P+3 binding pocket in the SH2
domain [25].
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Further analysis of Grb14 tyrosine phosphorylation
will no doubt provide information that may help eluci-
date the role of this protein in Tie2 signaling. Mapping
the tyrosines on Grb14 which become tyrosine phos-
phorylated may give us a clue as to what other proteins
bind and are involved in Grb14 signaling. Tyr67 on
Grb10 was identified as major site of phosphorylation in
response to insulin signaling. However, this site is not
conserved in Grb7 and 14. Interestingly, mutation of
this site increased affinity of Grb10 for IR. This raises
the possibility that tyrosine phosphorylation may be
involved in terminating Grb signaling at the receptor
level. Alternatively, it may suggest that Grb tyrosine
phosphorylation recruits this adaptor for involvement in
non-receptor mediated signaling pathways. Further
understanding of these sorts of post-translational modi-
fications seen in the Grb family will no doubt shed con-
siderable insight into their biological role.
Conclusions
Grb14 becomes tyrosine phosphorylated upon Tie2 acti-
vation and this tyrosine phosphorylation is dependent
upon tyrosine residues 1100 and 1106 of Tie2.
Methods
Expression vectors
The cDNAs representing wild type (WT), kinase-inactive
(K853A) and Y1111F Tie2/Tie-2 in pcDNA3.1 have been
described previously [5]. The cDNA encoding Grb14 was
a kind gift from Roger Daly. The cDN encoding the full
length Grb14 [10] was used as a template to generate an
arginine-to-lysine point mutation with the QuickChange
site-directed mutagenesis kit (Stratagene). Mutation was
confirmed by sequencing. GST fusion proteins were
described previously [5].
Production of GST fusion proteins
GST fusion proteins were prepared from Escherichia coli
using standard procedures. Recombinant proteins were
immobilized on glutathione-Sepharose beads (Amersham)
at 4°C for 30 minutes and analyzed by SDS-polyacrylamide
gel electrophoresis followed by Coomassie Blue staining.
Bovine serum albumin standards were used as a compari-
son to estimate protein concentration.
Cell Culture and Antibodies
Human umbilical vein endothelail (HUVEC) cells C166,
SVR, SVEC and HEK293T and HEK293Tie2 (a gift of
Fu-Kuen Lin, Amgen) cells were grown on 10-cm plates
in Dulbecco’s modified Eagle’s medium (DMEM)
(Sigma) supplemented with 10% FBS, 1% penicillin, 1%
streptomycin, and 200mM L-glutamine. EA.hy926 cells
were further supplemented with hypoxanthine, aminop-
terin and thymidine (Sigma) and HEK293Tie2 cells were
further supplemented with 250 mg/ml G418 (Life Tech-
nologies, Inc.), and 100 nM methotrexate (Sigma). Anti-
bodies used were as follows: polyclonal anti-Tie2 C-20
(Santa Cruz), monoclonal anti-phosphotyrosine 4G10
(Upstate Biotechnology Inc.), monoclonal anti-Tie2
(Pharmingen), monoclonal anti-Flag M2 (Sigma), poly-
clonal phospho-Tie2 (992) (Cell Signaling Technology).
GST mixing experiments, coimmunoprecipitation
experiments, and Western blotting procedures have
been previously described [5,15]. COMP-Ang1 was a
kind gift of GY Koh, Korea.
Transfection Procedures
HEK293T cells were cultured to ~75% confluency in 10-
cm cell culture plates and transfected with 2 μg DNA
using the lipofectamine reagent (Invitrogen Life Tech-
nologies) and according to manufactures protocol. Cells
were harvested after 48 h.
In Vitro Kinase Assay
Kinase assays were performed as follows: Cell lysates
were immunoprecipitated with anti-Tie2 antibodies for 2
h at 4°C. Immunoprecipitates were washed 3x in PLC
lysis buffer (without sodium fluoride or sodium pyropho-
sphate) [15] and 2x in kinase buffer (2 mM MnCl2 + 50
mM HEPES pH 7.5 + 10 mM MgCl2 + 0.2 mM dithio-
threitol) and then incubated with 4 μg of either GST or
GST-Dok-PΔPH as substrate including 40 μCi of [g-32P]
ATP (Amersham Biosciences), 20 μM ATP (Amersham
Biosciences) for 30 min at 30°C [26]. Kinase reactions
were stopped by the addition of 2x SDS-containing sam-
ple buffer and boiled for 10 min. Immunoprecipitates
were electrophoresed and half the gel was used to resolve
Tie2/Tie-2 expression by Western analysis using anti-
Tie-2 antibodies while the other half was dried and
exposed to phosphorimager analysis and quantification
(ImageQuant). The representative values of Tie2 kinase
activity were reflected as the value of GST-Dok-PΔPH
phosphorylation over the amount of immunoprecipitated
Tie2 in each of the samples. All experiments were per-
formed twice or more times with similar results.
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